Effects of apolipoprotein(a) size polymorphism and lipoprotein(a) concetrations combinedwith other risk factors on cad development

dc.creator	Jelić-Ivanović, Zorana
dc.creator	Bogavac-Stanojević, Nataša
dc.creator	Spasojević-Kalimanovska, Vesna
dc.creator	Spasić, S.
dc.creator	Memon, Lidija
dc.creator	Kalimanovska-Oštrić, Dimitra
dc.date.accessioned	2019-09-02T11:13:02Z
dc.date.available	2019-09-02T11:13:02Z
dc.date.issued	2008
dc.identifier.issn	1567-5688
dc.identifier.uri	https://farfar.pharmacy.bg.ac.rs/handle/123456789/1057
dc.publisher	Elsevier Ireland Ltd, Clare
dc.rights	restrictedAccess
dc.source	Atherosclerosis Supplements
dc.title	Effects of apolipoprotein(a) size polymorphism and lipoprotein(a) concetrations combinedwith other risk factors on cad development	en
dc.type	conferenceObject
dc.rights.license	ARR
dcterms.abstract	Богавац-Станојевић, Наташа; Јелић-Ивановић, Зорана; Спасић, С.; Мемон, Лидија; Спасојевић-Калимановска, Весна; Калимановска-Оштрић, Димитра;
dc.citation.volume	9
dc.citation.issue	1
dc.citation.spage	107
dc.citation.epage	107
dc.citation.other	9(1): 107-107
dc.citation.rank	M21
dc.description.other	77th Congress of the European Atherosclerosis Society 26-29 April 2008 • Istanbul, Turkey
dc.identifier.wos	000207610701147
dc.identifier.doi	10.1016/S1567-5688(08)70428-8
dc.type.version	publishedVersion